ADA	adalimumab
ATG16L1	autophagy-related 16 like 1
C11orf30	EMSY transcriptional repressor, BRCA2 interacting
CASP9	caspase 9
CCNY	cyclin Y
CD	Crohn’s disease
CD14	CD14 molecule
CDAI	Crohn’s Disease Activity Index
CDKAL1	CDK5 regulatory subunit associated protein 1 like 1
CI	confidence interval
CNTN5	contactin 5
CRP	C-reactive protein
CXCL12	C-X-C motif chemokine ligand 12
FAS-L	Fas ligand
FCGR3A	Fc gamma receptor IIIa
HAUS6	HAUS augmin-like complex subunit 6
HBI	Harvey–Bradshaw Index
HLA-DQA1*05	major histocompatibility complex, class II, DQ alpha 1
IBD	inflammatory bowel disease
IBDQ	Inflammatory Bowel Disease Questionnaire
IFNG	interferon gamma
IFX	infliximab
IL-	interleukin (1B, 6, 10, 12, 13, 17A, 18, 23 or 27)
IL1RN	interleukin 1 receptor antagonist
IRF1-AS1 (CARINH)	colitis-associated IRF1 antisense regulator of intestinal homeostasis
JAK2	Janus kinase 2
LY96	lymphocyte antigen 96
NFKBIA	NFKB inhibitor Alpha
NLRP3	NLR family pyrin domain containing 3
NR12	greater CFTR locus negative regulatory element NR12
OR	odds ratio
PHACTR3	phosphatase and actin regulator 3
PLIN2	perilipin 2
PTGER4	prostaglandin E receptor 4
PTPN2	protein tyrosine phosphatase non-receptor type 2
PUCAI	Pediatric Ulcerative Colitis Activity Index
SNP	single nucleotide polymorphism
Th17	lymphocyte T helper 17
TH2LCRR	T helper type 2 locus control region-associated RNA
TLR	toll-like receptor (2, 4 or 9)
TNF	tumor necrosis factor
TNFAIP3	TNF alpha-induced protein 3
TNFR	TNF receptor (type 1 or 2)
TNFRSF1	TNF receptor superfamily member 1 (A or B)
TNFSF	TNF superfamily member (4 or 18)
UC	ulcerative colitis
UST	ustekinumab
wPCDAI	Weighted Pediatric Crohn’s Disease Activity Index